Cdk5-dependent regulation of glucose-stimulated insulin secretion
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complications. Present treatments to reduce hyperglycemia mainly target the ATP-sensitive K(+) (K(ATP)) channel of pancreatic beta cells to increase insulin secretion. These current approaches are often associated with the side effect of hypoglycemia. Here we show that inhibition of the activity of cyclin-dependent kinase 5 (Cdk5) enhanced insulin secretion under conditions of stimulation by high glucose but not low glucose in MIN6 cells and pancreatic islets. The role of Cdk5 in regulation of insulin secretion was confirmed in pancreatic beta cells deficient in p35, an activator of Cdk5. p35-knockout mice also showed enhanced insulin secretion in response to a glucose challenge. Cdk5 kinase inhibition enhanced the inward whole-cell Ca(2+) channel current and increased Ca(2+) influx across the L-type voltage-dependent Ca(2+) channel (L-VDCC) upon stimulation with high glucose in beta cells, but had no effect on Ca(2+) influx without glucose stimulation. The inhibitory regulation by Cdk5 on the L-VDCC was attributed to the phosphorylation of loop II-III of the alpha(1C) subunit of L-VDCC at Ser783, which prevented the binding to SNARE proteins and subsequently resulted in a decrease of the activity of L-VDCC. These results suggest that Cdk5/p35 may be a drug target for the regulation of glucose-stimulated insulin secretion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CDK5 has been implicated in the regulation of pancreatic beta cell function, through formation of p35/CDK5 complexes that downregulate insulin expression (11, 12).”
From Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes (2007) · cites this paper as [12]
Citations
Cites
Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea Receptor
Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., & Bryan, J. (1995) · Science · doi:10.1126/science.270.5239.1166 · Cited by 1,709
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008 · cited 1×
“dtd" [ ]> Tight glycemic control in individuals with diabetes mellitus is essential to prevent or delay its complication”
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Tsai, L.-H., Delalle, I., Caviness, V. S., Chae, T., & Harlow, E. (1994) · Nature · doi:10.1038/371419a0 · Cited by 922
Chae, T., Kwon, Y. T., Bronson, R., Dikkes, P., Li, E., & Tsai, L.-H. (1997) · Neuron · doi:10.1016/s0896-6273(01)80044-1 · Cited by 715 · cited 1×
“We further investigated Ca 2+ influx in beta cells isolated from p35-knockout mice, in which Cdk5 kinase activity is extremely lo”
BackgroundInhibition of Cyclin‐Dependent Kinases by Purine Analogues
Veselý, J., Havliček, L., Strnad, M., Blow, J. J., Donella‐Deana, A., Pinna, L., Letham, D. S., Kato, J., Detivaud, L., Leclerc, S., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00771.x · Cited by 632
A brain-specific activator of cyclin-dependent kinase 5
Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., & Wang, J. H. (1994) · Nature · doi:10.1038/371423a0 · Cited by 579
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481
Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system
Tsai, L.-H., Takahashi, T., Caviness, V. S., & Harlow, E. (1993) · Development · doi:10.1242/dev.119.4.1029 · Cited by 457
An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) Activator
Tang, D., Yeung, J., Lee, K.-Y., Matsushita, M., Matsui, H., Tomizawa, K., Hatase, O., & Wang, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26897 · Cited by 340
Self-citationTriggering and Augmentation Mechanisms, Granule Pools, and Biphasic Insulin Secretion
Bratanova-Tochkova, T. K., Cheng, H., Daniel, S., Gunawardana, S., Liu, Y.-J., Mulvaney-Musa, J., Schermerhorn, T., Straub, S. G., Yajima, H., & Sharp, G. W. G. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s83 · Cited by 291 · cited 1×
“The biochemical mechanism of insulin secretion has been studied extensively with the aim of identifying target molecules for the treatment of diabete”
Background
Cited by
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2043 · Cited by 1,072
“In pancreatic beta cells, CDK5 has been shown to have a role in the loss of beta cell function under glucotoxic condition”
BackgroundGenome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
“CDK5 is implicated in reduced β-cell function, through the formation of p35–CDK5 complexes, which downregulate insulin expressio”
BackgroundVolkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420
“(Figure 2C) CDK5R1 acts as an activator of CDK5 (Ubeda et al , 2004) whose expression is regulated by glucose and which inhibits insulin secretion (Wei et al , 2005).”
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Pellarin, I., Dall’Acqua, A., Favero, A., Segatto, I., Rossi, V., Crestan, N., Karimbayli, J., Belletti, B., & Baldassarre, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02080-z · Cited by 304
ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function
Pi, J., Zhang, Q., Fu, J., Woods, C. G., Hou, Y., Corkey, B. E., Collins, S., & Andersen, M. E. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.05.025 · Cited by 334
“…al., 2004), NADH shuttle (Eto et al., 1999), transcription factor NF-κB (Norlin et al., 2005), protein kinases including cyclin-dependent kinase 5 (Wei et al., 2005), cAMP-dependent protein kinase (Wollheim and Maechler, 2002), PKC (Jones and Persaud, 1998) and cyclic pathways of pyruvate…”
Cyclin-Dependent Kinases in Brain Development and Disease
Su, S. C., & Tsai, L.-H. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154023 · Cited by 303
Deficit of tRNALys modification by Cdkal1 causes the development of type 2 diabetes in mice
Wei, F.-Y., Suzuki, T., Watanabe, S., Kimura, S., Kaitsuka, T., Fujimura, A., Matsui, H., Atta, M., Michiue, H., Fontecave, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58056 · Cited by 262
“We previously reported that Cdk5 regulates insulin secretion in pancreatic β cells (19).”
BackgroundSelf-citationCyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
Łukasik, P., Załuski, M., & Gutowska, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062935 · Cited by 245
“The inhibitory phosphorylation by CDK5 on the L-type voltage-dependent Ca2+ channel (LVDCC) at Ser783 prevents the binding of L-VDCC to SNARE proteins, thereby preventing exocytosis of insulin from the cell (pancreatic β-cells) (Figure 1) [45].”
BackgroundCho, Y. M., Kim, T. H., Lim, S., Choi, S. H., Shin, H. D., Lee, H. K., Park, K. S., & Jang, H. C. (2009) · Diabetologia · doi:10.1007/s00125-008-1196-4 · Cited by 243
“CDK5 has been suggested to downregulate insulin expression through the formation of p35/CDK5 complexes [39, 40].”
BackgroundCyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.012 · Cited by 237
Structure and Function of Noncanonical Nucleobases
Carell, T., Brandmayr, C., Hienzsch, A., Müller, M., Pearson, D., Reiter, V., Thoma, I., Thumbs, P., & Wagner, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201193 · Cited by 191
Lee, Y.-H., Kang, E. S., Kim, S. H., Han, S. J., Kim, C. H., Kim, H. J., Ahn, C. W., Cha, B. S., Nam, M., Nam, C. M., et al. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0341-8 · Cited by 177
“Considering the findings that inhibition of CDK5 prevented the decrease of insulin gene expression by restoring PDX-1, CDKAL1 may play an important role in CDK5-mediated regulation of beta cell function (Wei et al. 2005; Ubeda et al. 2006).”
BackgroundAn Unusual Member of the Cdk Family: Cdk5
Dhariwala, F. A., & Rajadhyaksha, M. S. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9242-1 · Cited by 164
Echalier, A., Bettayeb, K., Ferandin, Y., Lozach, O., Clément, M., Valette, A., Liger, F., Marquet, B., Morris, J. C., Endicott, J. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700940h · Cited by 162
The Role of Cdk5 in Neuroendocrine Thyroid Cancer
Pozo, K., Castro-Rivera, E., Tan, C., Plattner, F., Schwach, G., Siegl, V., Meyer, D., Guo, A., Gundara, J., Mettlach, G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.027 · Cited by 150
“It modulates insulin secretion in pancreatic b cells (Lilja et al., 2001; Wei et al., 2005) and may contribute to cell cycle regulation and some forms of cancer (Goodyear and Sharma, 2007; Jiang et al., 2005; Kim et al., 2006; Lin et al., 2007; Lopes and Agostinho, 2011; Strock et al., 2006).”
BackgroundPao, P., & Tsai, L. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00774-y · Cited by 174
Cyclin‐dependent kinase 5 in synaptic plasticity, learning and memory
Angelo, M., Plattner, F., & Giese, K. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04040.x · Cited by 133
“Work in models of synapse formation has demonstrated that Cdk5 promotes the formation of synaptic structures, possibly by inducing the expression and clustering of acetylcholine receptors in the post-synaptic membrane (Fu et al. 2005; Johansson et al. 2005; Lin et al. 2005).”
BackgroundMao, H., Li, Q., & Gao, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045882 · Cited by 132
Kinases and kinase signaling pathways: Potential therapeutic targets in Parkinson's disease
Wang, G., Pan, J., & Chen, S. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.003 · Cited by 124
“Among them, the stimulatory and inhibitory roles of CDK5 on insulin secretion have been attributed to the phosphorylation of Munc18 (Lilja et al., 2004), and a serine in the ac1 subunit of the L-type voltage-gated Ca2+-channels (Wei et al., 2005), respectively.”
BackgroundKono, T., Ahn, G., Moss, D. R., Gann, L., Zarain-Herzberg, A., Nishiki, Y., Fueger, P. T., Ogihara, T., & Evans-Molina, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1181 · Cited by 118
Biological functions of CDK5 and potential CDK5 targeted clinical treatments
Shupp, A., Casimiro, M. C., & Pestell, R. G. (2017) · Oncotarget · doi:10.18632/oncotarget.14538 · Cited by 112
“Outside of the nervous system, active CDK5 has been found in pancreatic β cells [13], corneal epithelial cells [14] and monocytes [15] amongst various other cell types [10, 16].”
BackgroundZhu, Y. X., Tiedemann, R. E., Shi, C.-X., Yin, H., Schmidt, J. E., Bruins, L. A., Keats, J. J., Braggio, E., Sereduk, C., Mousses, S., et al. (2011) · Blood · doi:10.1182/blood-2010-08-304022 · Cited by 118
Bai, B., Liang, Y., Xu, C., Lee, M. Y. K., Xu, A., Wu, D., Vanhoutte, P. M., & Wang, Y. (2012) · Circulation · doi:10.1161/circulationaha.112.118778 · Cited by 105
Extraneuronal roles of cyclin‐dependent kinase 5
Rosales, J. L., & Lee, K. (2006) · BioEssays · doi:10.1002/bies.20473 · Cited by 129
Ren, J., Jin, P., Wang, E., Liu, E., Harlan, D. M., Li, X., & Stroncek, D. F. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-1 · Cited by 114
Aguilar, V., & Fajas, L. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000089 · Cited by 100
Stukenbrock, H., Mußmann, R., Geese, M., Ferandin, Y., Lozach, O., Lemcke, T., Kegel, S., Lomow, A., Burk, U., Dohrmann, C. E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701582f · Cited by 101
Kang, M., Chung, J., & Ryoo, H. D. (2012) · Nature Cell Biology · doi:10.1038/ncb2447 · Cited by 110
Wang, Y., Nie, M., Li, W., Ping, F., Hu, Y., Ma, L., Gao, J., & Liu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026953 · Cited by 90
Stančáková, A., Pihlajamäki, J., Kuusisto, J., Stefan, N., Fritsche, A., Häring, H. U., Andreozzi, F., Succurro, E., Sesti, G., Boesgaard, T. W., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2218 · Cited by 88
Going out of the brain: Non-nervous system physiological and pathological functions of Cdk5
Contreras-Vallejos, E., Utreras, E., & González-Billault, C. E. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.022 · Cited by 100
Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5
Arif, A. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.027 · Cited by 96
Eggers, J. P., Grandgenett, P. M., Collisson, E. C., Lewallen, M. E., Tremayne, J. R., Singh, P. K., Swanson, B. J., Andersen, J. M., Caffrey, T. C., High, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2288 · Cited by 81
“and independently decrease insulin synthesis and secretion (50, 51).”
Glutathione‐S‐transferase P1 is a critical regulator of Cdk5 kinase activity
Sun, K., Chang, K., Clawson, S., Ghosh, S., Mirzaei, H., Regnier, F. E., & Shah, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07343.x · Cited by 79
Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation
Sakamaki, J.-I., Fu, A., Reeks, C., Baird, S., Depatie, C., Al Azzabi, M., Bardeesy, N., Gingras, A.-C., Yee, S.-P., & Screaton, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2919 · Cited by 77
Popowycz, F., Fournet, G., Schneider, C., Bettayeb, K., Ferandin, Y., Lamigeon, C., Tirado, Ò. M., Mateo‐Lozano, S., Notario, V., Colas, P., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801340z · Cited by 80
Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study
D.E.S.I.R. Study Group, Cauchi, S., Cavalcanti-Proença, C., Choquet, H., Gaget, S., Graeve, F. D., Marre, M., Balkau, B., Tichet, J., Meyre, D., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0295-x · Cited by 83
“CDKAL1 is also highly expressed in human islets [2] and shares homology with a known inhibitor of CDK5 activation which is implicated in beta-cell function [15].”
BackgroundWei, F., & Tomizawa, K. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0099 · Cited by 83
Self-citationDeletion of CDKAL1 Affects Mitochondrial ATP Generation and First-Phase Insulin Exocytosis
Ohara‐Imaizumi, M., Yoshida, M., Aoyagi, K., Saito, T., Okamura, T., Takenaka, H., Akimoto, Y., Nakamichi, Y., Yanobu‐Takanashi, R., Nishiwaki, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015553 · Cited by 74
The skeleton in the closet: actin cytoskeletal remodeling in β-cell function
Arous, C., & Halban, P. A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00268.2015 · Cited by 72
Essential Role of Ubiquitin-Proteasome System in Normal Regulation of Insulin Secretion
Kawaguchi, M., Minami, K., Nagashima, K., & Seino, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601228200 · Cited by 62
Self-citationKarunakaran, U., Elumalai, S., Moon, J. S., Jeon, J., Kim, N. D., Park, K., Won, K. C., Leem, J., & Lee, I. K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0052 · Cited by 63
Arif, A., Jia, J., Moodt, R. A., DiCorleto, P. E., & Fox, P. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011275108 · Cited by 59
“Glucose-induced inactivation of Cdk5/p35 in pancreatic β cells is implicated in glucotoxicity and diabetes (36, 37).”
BackgroundLalioti, V., Muruais, G., Dinarina, A., van Damme, J., Vandekerckhove, J., & Sandoval, I. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900218106 · Cited by 61
“Cdk5 plays a crucial regulatory role in glucosestimulated insulin secretion in pancreatic cells (7, 8).”
BackgroundInhibition of Cdk5 Promotes β-Cell Differentiation From Ductal Progenitors
Liu, K., Leuckx, G., Sakano, D., Seymour, P. A., Mattsson, C. L., Rautio, L., Staels, W., Verdonck, Y., Serup, P., Kume, S., et al. (2017) · Diabetes · doi:10.2337/db16-1587 · Cited by 58
“First, pharmacological inhibition of Cdk5 in isolated rodent islets and genetic knockout of p35 in mice enhanced glucose-stimulated insulin secretion, and performance in glucose tolerance tests was improved in the p35-knockout mice (29).”
BackgroundMechanisms of Disease: genetic insights into the etiology of type 2 diabetes and obesity
Lindgren, C. M., & McCarthy, M. I. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0723 · Cited by 63
Cyclin-Dependent Kinase 5 Promotes Pancreatic β-Cell Survival via Fak-Akt Signaling Pathways
Daval, M., Gurlo, T., Costes, S., Huang, C., & Butler, P. C. (2011) · Diabetes · doi:10.2337/db10-1048 · Cited by 52
A kinase of many talents: non-neuronal functions of CDK5 in development and disease
Sharma, S., & Siciński, P. (2020) · Open Biology · doi:10.1098/rsob.190287 · Cited by 59
“However, when roscovitine or olomoucine were combined with pharmacological compounds that increase endogenous insulin secretion such as glibenclamide, sulfonylurea or glucagon-like peptide 1 (GLP-1), CDK5 inhibition had an additive effect on insulin secretion in both high-glucose and low-glucose conditions [42,43].”
BackgroundMultisite Phosphorylation of S6K1 Directs a Kinase Phospho-code that Determines Substrate Selection
Arif, A., Jia, J., Willard, B. B., Li, X., & Fox, P. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.017 · Cited by 54
“Cdk5/p35 is also critical for insulin secretion by pancreatic islets in response to glucose challenge (Ubeda et al., 2004; Wei et al., 2005).”
Fueling the Cycle: CDKs in Carbon and Energy Metabolism
Solaki, M., & Ewald, J. C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00093 · Cited by 49
The Role of CDK5 in Tumours and Tumour Microenvironments
Do, P. A., & Lee, C. H. (2020) · Cancers · doi:10.3390/cancers13010101 · Cited by 56
Ghassibe‐Sabbagh, M., Haber, M., Salloum, A. K., Al-Sarraj, Y. A., Akle, Y., Hirbli, K., Romanos, J., Mouzaya, F., Gauguier, D., Platt, D. E., et al. (2014) · Scientific Reports · doi:10.1038/srep07351 · Cited by 52
Chistiakov, D. A., Potapov, V. A., Андреевна, С. С., Бельчикова, Л. Н., Суплотова, Л. А., & Nosikov, V. V. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0299-4 · Cited by 45
“voltage-dependent Ca channel (L-VDCC) at Ser783 thereby inhibiting Ca efflux into the beta-cell and insulin secretion [7].”
BackgroundTaniguchi, M., Taoka, M., Itakura, M., Asada, A., Saito, T., Kinoshita, M., Takahashi, M., Isobe, T., & Hisanaga, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609457200 · Cited by 48
A new era for Type 2 diabetes genetics
Zeggini, E. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02274.x · Cited by 52
Chatterjee, A., Cutler, S. J., Doerksen, R. J., Khan, I. A., & Williamson, J. S. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.09.043 · Cited by 44
Sulwon Lecture 2009: The Search for Genetic Risk Factors of Type 2 Diabetes Mellitus
Park, K. S. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.1.12 · Cited by 54
“CDKAL1 encodes CDK5 regulatory subunit-associated protein 1-like 1 [28], which is thought to inhibit cyclin-dependent kinase 5 (CDK5) activity by binding to the CDK5 activator p35 [34].”
BackgroundAssociation of gene variants with susceptibility to type 2 diabetes among Omanis
Al-Sinani, S., Woodhouse, N., Al-Mamari, A., Al-Shafie, O., Al-Shafaee, M., Al-Yahyaee, S., Hassan, M., Jaju, D., Al-Hashmi, K., Al-Abri, M., et al. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.358 · Cited by 47
β2-Syntrophin Is a Cdk5 Substrate That Restrains the Motility of Insulin Secretory Granules
Schubert, S., Knoch, K.-P., Ouwendijk, J., Mohammed, S., Bodrov, Y., Jäger, M., Altkrüger, A., Wegbrod, C., Adams, M. E., Kim, Y. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012929 · Cited by 47
Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion
Lee, H. Y., Jung, H., Jang, I. H., Suh, P., & Ryu, S. H. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.009 · Cited by 41
Liebl, J., Fürst, R., Vollmar, A. M., & Zahler, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.06.020 · Cited by 56
Demange, L., Abdellah, F. N., Lozach, O., Ferandin, Y., Gresh, N., Meijer, L., & Galons, H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.141 · Cited by 37
Gene–Nutrient Interactions in the Metabolic Syndrome
Phillips, C. M., Tierney, A. C., & Roche, H. M. (2008) · Lifestyle Genomics · doi:10.1159/000112461 · Cited by 42
“This study found that the TCF7L2 SNP rs7903146 conferred the most significant risk. In addition to confirming the association between the risk variants of SLC30A8 and HHEX with T2DM they also identified a variant in CDKAL1 that was associated with T2DM in European ancestry and Han Chinese ancestry. The insulin respons…”
BackgroundKelly, A. C., Bidwell, C. A., McCarthy, F., Taska, D. J., Anderson, M. J., Camacho, L. E., & Limesand, S. W. (2017) · Endocrinology · doi:10.1210/en.2016-1901 · Cited by 41
“CDKL5, similar to CDK5, might regulate insulin exocytosis (29, 30).”
BackgroundBrambillasca, S., Altkrüger, A., Colombo, S. F., Friederich, A., Eickelmann, P., Mark, M., Borgese, N., & Solimena, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376558 · Cited by 41
MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus
Wang, W., Wang, J., Yan, M., Jiang, J., & Bian, A.-L. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.097 · Cited by 34
Lasram, K., Halim, N. B., Benrahma, H., Médiène-Benchekor, S., Arfa, I., Hsouna, S., Kéfi, R., Jamoussi, H., Ammar, S. B., Bahri, S., et al. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12147 · Cited by 32
Pin, F., Buron, F., Saab, F., Colliandre, L., Bourg, S., Schoentgen, F., Guével, R. L., Guguen‐Guillouzo, C., & Routier, S. (2011) · MedChemComm · doi:10.1039/c1md00141h · Cited by 34
Karunakaran, U., Lee, J. E., Elumalai, S., Moon, J. S., & Won, K. C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.038 · Cited by 33
Habitual coffee intake, genetic polymorphisms, and type 2 diabetes
Lee, J. K., Kim, K., Ahn, Y., Yang, M., & Lee, J. E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0805 · Cited by 38
Xiao, S., Zeng, X., Fan, Y., Su, Y., Ma, Q., Zhu, J., & Yao, H. (2016) · PubMed Central · doi:10.12659/msm.895347 · Cited by 33
“Due to the regulatory effects of CDK5 on insulin secretion [21,22], CDKAL1 is suspected to influence insulin secretion by regulating the activity of CDK5.”
BackgroundGenomic regulatory blocks in vertebrates and implications in human disease
Navratilova, P., & Becker, T. S. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp019 · Cited by 35
“regulation of insulin secretion [71], but in light of the”
BackgroundNikitin, A. G., Potapov, V. Y., Brovkina, O., Koksharova, E., Ходырев, Д. С., Philippov, Y. I., Michurova, M. S., Шамхалова, М. Ш., Vikulova, O. K., Андреевна, С. С., et al. (2017) · PeerJ · doi:10.7717/peerj.3414 · Cited by 31
“It has been shown that CDKAL1 also acts as an inhibitor in pancreatic β-cells; CDK5 kinase activity plays a significant role in the efficiency of insulin granule secretion into the bloodstream (Wei et al., 2005; Ubeda, Rukstalis & Habener, 2006).”
BackgroundNew life for antidiabetic drugs
Houtkooper, R. H., & Auwerx, J. H. (2010) · Nature · doi:10.1038/466443a · Cited by 29
Struktur und Funktion nicht‐kanonischer Nukleobasen
Carell, T., Brandmayr, C., Hienzsch, A., Müller, M., Pearson, D., Reiter, V., Thoma, I., Thumbs, P., & Wagner, M. (2012) · Angewandte Chemie · doi:10.1002/ange.201201193 · Cited by 29
Ghosh, C., Das, N., Saha, S., Kundu, T., Sircar, D., & Roy, P. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00953-6 · Cited by 32
“Cdk5 is expressed throughout the mammalian tissues ubiquitously, but expression of its co-activators (P35 and P39) is limited to neural and the pancreatic tissues only, as a result of which its kinase activity is restricted to those specific tissues [15].”
BackgroundLu, F., Qian, Y., Li, H., Dong, M., Lin, Y., Du, J., Lin, Y., Chen, J., Shen, C., Jin, G., et al. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.25 · Cited by 30
Cyclin-Dependent Kinase 5 Phosphorylates Endothelial Nitric Oxide Synthase at Serine 116
Cho, D., Seo, J., Park, J., Jo, C., Choi, Y. J., Soh, J., & Jo, I. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140210 · Cited by 33
A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases
Batra, S., Jahan, S., Ashraf, A., Alharbi, B., Jawaid, T., Islam, A., & Hassan, M. I. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123259 · Cited by 28
Terabayashi, T., Sakaguchi, M., Shinmyozu, K., Ohshima, T., Johjima, A., Ogura, T., Miki, H., & Nishinakamura, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039714 · Cited by 28
Self-citationJin, J., Park, J., Kim, K., KANG, Y. Y., Park, S. G., Kim, J. H., Park, K. S., Jun, H., & Kim, Y. (2009) · Journal of Proteome Research · doi:10.1021/pr800765t · Cited by 29
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
Oner, M., Lin, E., Chen, M., Hsu, F.-N., Prince, G. M. S. H., Chiu, K.-Y., Teng, C. J., Yang, T., Wang, H., Yue, C.-H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163881 · Cited by 29
“CDK5 is essential for the regulation of insulin secretion in pancreatic β cells [21].”
BackgroundGenome-wide association scans for Type 2 diabetes: new insights into biology and therapy
McCarthy, M. I., & Zeggini, E. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.008 · Cited by 31
Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome
Song, L., Park, S.-H. E., Isseroff, Y., Morikawa, K., & Yazawa, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.028 · Cited by 30
“…reports indicating the potential regulation of Ca V 1.2 by CDK5 in pancreatic b cells and a neuronal progenitor cell line (Furu-sawa et al., 2014; Wei et al., 2005), our findings demonstrate that CDK5 plays an important role in regulating Ca V 1.2 functions in CMs and that the inhibition of CDK5…”
InfluentialCdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
Carter, A. M., Kumar, N., Herring, B., Tan, C., Guenter, R. E., Telange, R., Howse, W., Viol, F., McCaw, T. R., Bickerton, H. H., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00372-5 · Cited by 29
Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-dependent Kinase 5
Nguyen, C. T. N., Nishi, A., Kansy, J. W., Fernandez, J., Hayashi, K., Gillardon, F., Hemmings, H. C., Nairn, A. C., & Bibb, J. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701046200 · Cited by 27
Effects of the cyclin‐dependent kinase inhibitor R‐roscovitine on eosinophil survival and clearance
Farahi, N., Uller, L., Juss, J. K., Langton, A. J., Cowburn, A. S., Gibson, A., Foster, M. R., Farrow, S. N., Marco‐Casanova, P., Sobolewski, A., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03680.x · Cited by 29
Bao, X. Y., Peng, B., & Yang, M. S. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0995-8 · Cited by 27
“In the pancreatic islets, CDK5 plays a role in the regulation of b-cells function and insulin gene expression under glucotoxic conditions [ 30 , 31].”
BackgroundDiabetes: New conductors for the peroxisome proliferator-activated receptor γ (PPARγ) orchestra
Whitehead, J. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.04.017 · Cited by 31
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
Klemann, C. J. H. M., Martens, G. J. M., Poelmans, G., & Visser, J. E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9103-8 · Cited by 31
“VDCC function and thus calcium influx is inhibited by CDK5[145,146].”
BackgroundGenetic Risk Factors and Gene–Lifestyle Interactions in Gestational Diabetes
Jääskeläinen, T. J., & Klemetti, M. M. (2022) · Nutrients · doi:10.3390/nu14224799 · Cited by 35
“The exact function of CDKALI has not been established but it has been implicated in glucose-stimulated insulin secretion [84,85] and risk variants associated with impaired insulin secretory capacity [51].”
BackgroundRegulation of insulin secretion by the post-translational modifications
Yang, C., Wei, M., Zhao, Y., Yang, Z., Song, M., Mi, J., Yang, X., & Tian, G. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1217189 · Cited by 27
“A previous report showed that silencing CDK5 activator CDK5R1 (also known as p35) enhances insulin secretion in MIN6 cells in high glucose culture (Wei et al., 2005).”
BackgroundMahdizade, A. H., Bahreiny, S. S., Bastani, M., Dabbagh, M. R., Aghaei, M., Malayeri, F. A., YousefiFard, A., & Taghizadeh, E. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01272-7 · Cited by 25
“CDK5 reduces insulin secretion in response to glucose and is an essential factor in reducing insulin gene expression induced by glucose toxicity [22, 23].”
Novel genomic signals of recent selection in an Ethiopian population
Ayele, F. T., Adeyemo, A., Chen, G., Hailu, E., Aseffa, A., Davey, G., Newport, M. J., & Rotimi, C. N. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.233 · Cited by 26
Christodoulou, M., Avgeris, M., Kokkinopoulou, I., Maratou, E., Mitrou, P., Kontos, C. K., Pappas, E., Boutati, E. I., Scorilas, A., & Fragoulis, E. G. (2019) · Scientific Reports · doi:10.1038/s41598-018-37856-1 · Cited by 30
Zheng, Y.-L., Li, C., Hu, Y., Cao, L., Wang, H., Li, B., Lu, X., Bao, L., Luo, H., Shukla, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063332 · Cited by 28
Li, Y., Wang, L., Lu, X.-Z., Yang, Z., Wang, X., Zhou, C., Xu, J., Qian, Y., & Chen, A. (2013) · Scientific Reports · doi:10.1038/srep03131 · Cited by 24
A Cdk5 Inhibitor Enhances the Induction of Insulin Secretion by Exendin-4 Both in Vitro and in Vivo
Kitani, K., Oguma, S., Nishiki, T., Ohmori, I., Galons, H., Matsui, H., Meijer, L., & Tomizawa, K. (2007) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp006607 · Cited by 25
“Cdk5 phosphorylates loop II-III of the α1c subunit of L-VDCC and inhibits the channel activity, resulting in the inhibition of glucose-stimulated insulin secretion [15].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Wei, F.-Y., Nagashima, K., Ohshima, T., Saheki, Y., Lu, Y.-F., Matsushita, M., Yamada, Y., Mikoshiba, K., Seino, Y., Matsui, H., & Tomizawa, K.
- Affiliations
- Okayama University (JP)
- Kyoto University (JP)
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Tomizawa, Kazuhito
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-09-11
- Volume
- 11
- Issue
- 10
- Pages
- 1104-1108
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2016207732
- Cited by
- 199
- References
- 22
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 2 · 2023: 9 · 2022: 8 · 2021: 13 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 15 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 5 · 2012: 17
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- cyclin-dependent kinase 5, Cdk5/p35, glucose-stimulated insulin secretion, pancreatic beta cells, L-type voltage-dependent calcium channels, SNARE proteins, calcium influx, MIN6 cells, diabetes mellitus, hypoglycemia
- MeSH terms
- Insulin Secretion, Animals, Cell Line, Glucose, Insulin, Kinetin, Nerve Tissue Proteins, Signal Transduction, Insulin-Secreting Cells, Cyclin-Dependent Kinase 5, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.